Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lexeo Therapeutics
Biotech
Cardiff Oncology churns C-suite—Chutes & Ladders
Cardiff churns C-suite to advance cancer candidate. Lexeo lands Big Pharma cardiologist. Janux goes with Gilead vet Go as CMO.
Darren Incorvaia
,
Zoey Becker
Jan 30, 2026 8:30am
Lexeo, J&J team up on heart pump tech for gene therapy delivery
Jan 8, 2026 9:30am
Lexeo laid off 15% in April to focus on cardiac gene therapies
May 12, 2025 8:30am
Lexeo locks in pivotal trial plan as gene therapy data accrue
Apr 7, 2025 9:37am
Lexeo links gene therapy to improvements in rare heart disease
Jul 15, 2024 9:46am
Takeda welcomes new oncology chief from CRISPR—Chutes & Ladders
Feb 9, 2024 9:30am
